Biologic Agents (e.g., Rituximab, Dupilumab, Omalizumab) Cost in Korea
Mijan Mijan • July 29, 2025
Biologic Agents (e.g., Rituximab, Dupilumab, Omalizumab) Cost in Korea
Biologic agents are advanced targeted therapies used in Korea for treating severe autoimmune and inflammatory skin disorders such as atopic dermatitis, pemphigus, and chronic urticaria. These medications work by modulating specific components of the immune system to reduce symptoms and inflammation.
π Comprehensive Cost Overview
| Biologic Agent | Estimated Cost per Dose (KRW) | Typical Dosage |
|---|---|---|
| Rituximab | 1,500,000 – 3,500,000 | 375 mg/m² IV infusion, 1-2 doses |
| Dupilumab | 700,000 – 1,200,000 | 300 mg subcutaneous every 2 weeks |
| Omalizumab | 500,000 – 1,000,000 | 150-300 mg subcutaneous every 4 weeks |
π Detailed Cost Analysis by Component
| Item/Service | Cost (KRW) | Details |
|---|---|---|
| Initial Specialist Consultation | 50,000 – 100,000 | Assessment and therapy planning |
| Infusion or Injection Administration | 50,000 – 150,000 per session | Clinic or hospital visit charges |
| Routine Monitoring Tests | 30,000 – 70,000 per test | Blood work and immune function tests |
β Additional & Optional Services Cost
| Service | Estimated Cost (KRW) | Purpose |
|---|---|---|
| Pre-Treatment Screening | 40,000 – 80,000 | Tuberculosis and infection screening |
| Specialist Follow-Up | 40,000 – 90,000 | Ongoing management and adjustment |
π₯ Clinical Treatment Costs
| Facility Type | Cost Range (KRW) | Includes |
|---|---|---|
| Dermatology Clinics | 1,000,000 – 3,000,000 per dose | Medication, consultation, and injection |
| University Hospitals | 1,500,000 – 4,000,000 per dose | Comprehensive care including specialist follow-up |
This is a subtitle for your new post
This is a subtitle for your new post
